Dyne Therapeutics

Dyne Therapeutics

DYN· Manufacturing· Fiscal year ends in December

CEO pay in FY2024Stock +77.1% in FY2024

John G. Cox is the CEO of Dyne Therapeutics and was paid $20.7M in FY2024 (Dec).

Pay$100 in the stock at the end of FY23 → $177
CEO pay is from each Dyne Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1John G. CoxFY2024
  2. 2Douglas KerrFY2024
  3. 3Oxana BeskrovnayaFY2024
  4. 4Richard ScalzoFY2024
  5. 5Johanna Friedl-NadererFY2025
  6. 6Erick LuceraNot disclosed

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Dyne Therapeutics paid its one named executive on file $1.1M in FY2025 (Dec).

Name
Johanna Friedl-NadererChief Commercial OfficerNot disclosed
John G. CoxPresident and Chief Executive OfficerNot disclosedNot disclosed
Douglas KerrChief Medical OfficerNot disclosedNot disclosed
Oxana BeskrovnayaChief Innovation Officer; Former Chief Scientific OfficerNot disclosed
Richard ScalzoFormer Senior Vice President, Head of Finance and AdministrationNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers18

See all

The FY2025 (Dec) proxy of Dyne Therapeutics names 18 peer companies for pay. Pay versus performance data of Dyne Therapeutics for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Dirk KerstenDirector · 5 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive
  • Edward HurwitzDirector · 5 yr on the boardIndependentCompensation—Paid as an executive
  • Catherine Stehman-Breen, M.D.Director · 4 yr on the boardIndependentAudit, Research and Development—Paid as an executive
  • David C. LubnerDirector · 3 yr on the boardIndependentAudit (Chair), Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2023).

Shared directors

Activity

Filings6

See all
Proxy statementDEF 14AApr 23, 2026FY2025
Annual report10-KMar 2, 2026FY2025
Proxy statementDEF 14AApr 15, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 5, 2024FY2023
Annual report10-KMar 5, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data